Therefore, we performed a nested case–control study within the prospective Women's Health Initiative Study (WHI) to investigate the association between baseline serum concentrations of sRAGE and adiponectin, leptin, MCP1, and PAI1 and incident pancreatic cancer risk. This evidence concerns the gene ADIPOQ and pancreatic neoplasm.